Parabilis Medicines, Inc. · NASDAQ:PBLS
ARCH Venture Fund XII, L.P. reported a 5.30% stake in Parabilis Medicines, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
ARCH Venture Fund XII, L.P. reported a 5.30% stake in Parabilis Medicines, Inc., 6,412,780 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 5.30%
- Shares
- 6,412,780
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ARCH Venture Fund XII, L.P. | 5.30% | 6,412,780 |
| ARCH Venture Partners XII, L.P. | 5.30% | 6,412,780 |
| ARCH Venture Partners XII, LLC | 5.30% | 6,412,780 |
| Robert Nelsen | 5.30% | 6,412,780 |
| Keith Crandell | 5.30% | 6,412,780 |
| Kristina Burow | 5.30% | 6,412,780 |
| Steven Gillis | 5.30% | 6,412,780 |
Source
Related
- Parabilis Medicines, Inc.
- ARCH Venture Fund XII, L.P.
- Parabilis Medicines, Inc. shareholders
- Schedule 13G · FMR LLC · Aug 6, 2026
- Form 4 · Ra Capital Management, L.P. · Jul 22, 2026
- Form 4 · Soleus Capital Group, LLC · Jun 29, 2026
- Schedule 13D · Ra Capital Management, L.P. · Jun 18, 2026
- Form 4 · Sebulsky Alan · Jun 16, 2026